Day One Biopharmaceuticals (DAWN) Change in Cash (2022 - 2025)
Historic Change in Cash for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $7.7 million.
- Day One Biopharmaceuticals' Change in Cash fell 9582.03% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$379.5 million, marking a year-over-year decrease of 30898.53%. This contributed to the annual value of -$105.8 million for FY2024, which is 17271.48% down from last year.
- According to the latest figures from Q3 2025, Day One Biopharmaceuticals' Change in Cash is $7.7 million, which was down 9582.03% from $2.3 million recorded in Q2 2025.
- Day One Biopharmaceuticals' Change in Cash's 5-year high stood at $183.1 million during Q3 2024, with a 5-year trough of -$297.8 million in Q4 2024.
- In the last 4 years, Day One Biopharmaceuticals' Change in Cash had a median value of -$10.4 million in 2023 and averaged -$16.1 million.
- Within the past 5 years, the most significant YoY rise in Day One Biopharmaceuticals' Change in Cash was 25242.65% (2024), while the steepest drop was 276481.0% (2024).
- Quarter analysis of 4 years shows Day One Biopharmaceuticals' Change in Cash stood at -$35.6 million in 2022, then soared by 70.8% to -$10.4 million in 2023, then tumbled by 2764.81% to -$297.8 million in 2024, then surged by 102.57% to $7.7 million in 2025.
- Its last three reported values are $7.7 million in Q3 2025, $2.3 million for Q2 2025, and -$91.6 million during Q1 2025.